260 CD47 antibody, AO-176 demonstrates potent anti-tumor activity in pre-clinical solid tumor xenografts as a single agent and in combination with multiple classes of therapeutics

• Robyn Puro,
• Ronald Hiebsch,
• Michael Donio,
• Benjamin Capoccia,
• Arun Kashyap,
• Daniel Pereira,
• Gabriela Andrejeva,
• Rachel Delston,
• Casey Wilson

Affiliations

Robyn Puro

Arch Oncology, St. Louis, MO, USA

Ronald Hiebsch

Arch Oncology, St. Louis, MO, USA

Michael Donio

Arch Oncology, St. Louis, MO, USA

Benjamin Capoccia

Arch Oncology, St. Louis, MO, USA

Arun Kashyap

Arch Oncology, St. Louis, MO, USA

Daniel Pereira

Arch Oncology, St. Louis, MO, USA

Gabriela Andrejeva

Arch Oncology, St. Louis, MO, USA

Rachel Delston

Arch Oncology, St. Louis, MO, USA

Casey Wilson

Arch Oncology, St. Louis, MO, USA